Junyan Wang
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
PGAM5-mediated VDAC1 oligomerization Facilitates Ponatinib-Induced Cardiotoxicity via Disrupting the Mitophagy-Mitochondrial unfolded protein response Synergistic Defense Crosstalk.
Journal: Chemico-biological interactions
Published: April 30, 2026
Yixinjiedu Formula Attenuates Pressure Overload-Induced Cardiac Dysfunction by Suppressing Ferroptosis and Restoring Mitophagy via the PINK1/Parkin Axis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 16, 2025
PGAM1-dependent VDAC1 oligomerization disrupts mitochondrial quality control to drive doxorubicin cardiotoxicity via the cGAS-STING-ferroptosis axis.
Journal: Free radical biology & medicine
Published: October 20, 2025
Reversing diastolic dysfunction in diabetes: a mitochondrial quality control-centric pharmacological approach.
Journal: Acta diabetologica
Published: September 26, 2025
Perylenediimide-Based Donor-Acceptor MOF for Sunlight-Driven Photocatalytic N-α-C(sp3)-H Bond Functionalization of Tetrahydroisoquinoline.
Journal: Inorganic chemistry
Published: September 09, 2025
Dusp15 modulates mtHsp70 Thr116 phosphorylation state to preserve mito-UPR and attenuate cardiac dysfunction in diabetic cardiomyopathy.
Journal: Cardiovascular diabetology
Published: September 05, 2025
Chromosome-level genome assembly and annotation of the tropical sea cucumber Bohadschia ocellate.
Journal: Scientific data
Published: August 08, 2025
Unlocking Hopeaphenol: A Potent Ally Against Cardiac Hypertrophy via AMPK Activation.
Journal: Nutrients
Published: August 02, 2025
Icariin attenuates diabetic cardiomyopathy by activating Nrf2-dependent antioxidant and mitochondrial pathways: Integrative evidence from network pharmacology and experimental validation.
Journal: Journal of ethnopharmacology
Published: July 16, 2025
Silybin Mitigates Post-Myocardial Infarction Heart Failure in Mice via Modulation of HIF-1α-Driven Glycolysis and Energy Metabolism.
Journal: Nutrients
Published: July 14, 2025
Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 28, 2025
Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance.
Journal: Journal of nanobiotechnology
Published: March 21, 2025
Last Updated: 09/26/2026